Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma

NCT07389876 · clinicaltrials.gov ↗

RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Second-line Treatment

Interventions

DRUG: Albumin-bound Paclitaxel
DRUG: Immune Checkpoint Inhibitor
DRUG: Anti-angiogenic drug
DRUG: Trastuzumab emtansine

Sponsor

Fudan University